sofosbuvir has been researched along with Chronic Kidney Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (57.14) | 24.3611 |
| 2020's | 9 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Kao, JH; Liu, CH | 1 |
| Berg, T; Boeker, KHW; Buggisch, P; C-Registry, GH; Günther, R; Hinrichsen, H; Klinker, H; Manns, MP; Mauss, S; Müller, T; Serfert, Y; Wiegand, J; Zeuzem, S | 1 |
| Aghemo, A; Annalisa, S; Bella, D; Bhoori, S; Borghi, M; Brocchieri, A; Buscarini, E; Centenaro, R; Colombo, AE; Colombo, S; D'Ambrosio, R; Di Marco, M; Dionigi, E; Fagiuoli, S; Fanetti, I; Giorgini, A; Grossi, P; Invernizzi, P; Lampertico, P; Lazzaroni, S; Lombardi, A; Maggiolo, F; Mendeni, M; Menzaghi, B; Messina, E; Molteni, C; Monforte, AD; Noventa, F; Pan, A; Pasulo, L; Pigozzi, MG; Poggio, PD; Pozzoni, P; Puoti, M; Spinelli, O; Spinetti, A; Taddei, MT; Terreni, N; Viganò, P; Vinci, M; Zaltron, S; Zuin, M | 1 |
| Bruchfeld, A | 1 |
| Bonacini, M; Brainard, DM; De-Oertel, S; Flamm, SL; Gane, EJ; Gordon, SC; Huang, J; Hyland, RH; Kirby, BJ; Landis, CS; Lawitz, E; Maliakkal, BJ; Ortiz-Lasanta, G; Osinusi, AO; Robson, R; Zhang, J | 1 |
| Chen, H; Li, C; Liang, J; Tian, J; Xiang, H | 1 |
| Chang, CC; Chang, CH; Chang, CY; Chen, CY; Chen, JJ; Chen, PY; Fang, YJ; Hsieh, TY; Huang, CS; Huang, JJ; Huang, KJ; Huang, YJ; Kao, JH; Kao, WY; Lai, HC; Lee, FJ; Lee, PL; Liu, CH; Liu, CJ; Lo, CC; Peng, CY; Shih, YL; Su, PY; Su, WW; Tsai, MC; Tseng, CW; Tseng, KC; Yang, SS | 1 |
| Maajani, K; Majd Jabbari, S; Merat, S; Poustchi, H; Sepanlou, SG | 1 |
| Aghemo, A; Solitano, V | 1 |
| Martin, P; McQuaid, T; Sise, ME | 1 |
| Burman, B; Kozarek, RA; Park, JA; Shin, HP; Siddique, A | 1 |
| Ahn, SH; Lim, TS | 1 |
| Aggarwal, R; Bhadauria, DS; Goel, A; Gupta, A; Kaul, A; Mehrotra, M; Rai, P; Sharma, RK; Verma, P | 1 |
| Abe, H; Arai, T; Atsukawa, M; Hayama, K; Iio, E; Itokawa, N; Iwakiri, K; Kato, K; Kawamoto, C; Kondo, C; Kumada, T; Nakagawa-Iwashita, A; Okubo, T; Shimada, N; Tanaka, Y; Toyoda, H; Tsubota, A | 1 |
| Gupta, E; Kataria, A; Nayak, SL; Sarin, SK | 1 |
| Abdel-Razek, W; Waked, I | 1 |
| Kikuchi, K | 1 |
| Chen, J; Fang, Z; Li, M; Li, Y; Lin, Q | 1 |
| Chen, T; Chen, Y; Dong, J; Fu, S; He, Y; Hu, C; Li, J; Liu, J; Tian, Z; Wang, J; Yan, T; Yang, Y; Zhang, R; Zhao, F; Zhao, Y | 1 |
| Chung, RT; Fried, MW; Koraishy, FM; Liapakis, A; Lim, JK; Nelson, DR; Saxena, V; Schmidt, M; Sise, ME; Terrault, NA | 1 |
| Botta-Fridlund, D; Hachicha, M | 1 |
5 review(s) available for sofosbuvir and Chronic Kidney Diseases
| Article | Year |
|---|---|
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Quinoxalines; Renal Insufficiency, Chronic; Sofosbuvir; Sustained Virologic Response | 2022 |
An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease.
Topics: Antiviral Agents; Hepatitis C; Hepatitis C, Chronic; Humans; Renal Insufficiency, Chronic; Sofosbuvir; Treatment Outcome | 2021 |
Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Renal Dialysis; Renal Insufficiency, Chronic; Sofosbuvir; United States | 2022 |
Treatment of Hepatitis C Virus Infection in Dialysis Patients.
Topics: Antiviral Agents; Contraindications, Drug; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Japan; Renal Dialysis; Renal Insufficiency, Chronic; Sofosbuvir | 2018 |
Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4-5 chronic kidney disease: a systematic review and meta-analysis.
Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Prospective Studies; Renal Insufficiency, Chronic; Ribavirin; Sofosbuvir; Sustained Virologic Response | 2019 |
1 trial(s) available for sofosbuvir and Chronic Kidney Diseases
| Article | Year |
|---|---|
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; New Zealand; Non-Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Ribavirin; Safety; Sofosbuvir; Treatment Outcome; United States; Uridine Monophosphate; Viral Load | 2020 |
15 other study(ies) available for sofosbuvir and Chronic Kidney Diseases
| Article | Year |
|---|---|
Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
Topics: 2-Naphthylamine; Acute Disease; Adult; Aged; Anemia; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Fluorenes; Germany; Glomerular Filtration Rate; Hepatitis C, Chronic; Humans; Hypertension; Imidazoles; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Pleural Effusion; Proline; Pyrrolidines; Registries; Renal Insufficiency, Chronic; Ribavirin; Ritonavir; RNA, Viral; Severity of Illness Index; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine | 2019 |
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Italy; Logistic Models; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sofosbuvir; Sustained Virologic Response; Young Adult | 2020 |
HCV eradication in chronic kidney disease: ready for prime time?
Topics: Benzimidazoles; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Humans; Renal Insufficiency, Chronic; Ribavirin; Sofosbuvir | 2020 |
Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C.
Topics: Alanine Transaminase; Amides; Antiviral Agents; Aspartate Aminotransferases; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Isoquinolines; Male; Middle Aged; Pyrrolidines; Quinoxalines; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; RNA, Viral; Sofosbuvir; Sulfonamides; Valine; Viral Load | 2020 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Drug Combinations; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Ribavirin; Sofosbuvir; Sustained Virologic Response; Young Adult | 2022 |
Sofosbuvir in HCV patients with chronic kidney disease: No time for caution.
Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Renal Insufficiency, Chronic; Sofosbuvir; Sustained Virologic Response; Treatment Outcome | 2021 |
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Sofosbuvir; Sustained Virologic Response; Treatment Outcome | 2017 |
Use of sofosbuvir in chronic kidney disease: Is it necessary?
Topics: Genotype; Hepatitis C, Chronic; Humans; Renal Insufficiency, Chronic; Sofosbuvir | 2017 |
Daclatasvir and reduced-dose sofosbuvir: An effective and pangenotypic treatment for hepatitis C in patients with estimated glomerular filtration rate <30 mL/min.
Topics: Adult; Antiviral Agents; Carbamates; Comorbidity; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; India; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Renal Insufficiency, Chronic; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2019 |
Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Creatinine; Drug Resistance, Viral; Fluorenes; Genotype; Glomerular Filtration Rate; Hepatitis B virus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate; Young Adult | 2018 |
Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Carbamates; Drug Therapy, Combination; Drugs, Generic; Female; Fluorenes; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; India; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Renal Insufficiency, Chronic; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine; Viral Load; Young Adult | 2018 |
Editorial: is sofosbuvir-based therapy suitable for patients with advanced chronic kidney disease?
Topics: 2-Naphthylamine; Anilides; Benzimidazoles; Carbamates; Cyclopropanes; Fluorenes; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Proline; Renal Insufficiency, Chronic; Ritonavir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |
Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hyperkalemia; Male; Middle Aged; Recurrence; Renal Insufficiency, Chronic; Sofosbuvir; Sustained Virologic Response | 2019 |
Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Databases, Factual; Drug Therapy, Combination; Europe; Female; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; North America; Regression Analysis; Renal Dialysis; Renal Insufficiency, Chronic; Simeprevir; Sofosbuvir; Sustained Virologic Response; Young Adult | 2016 |
[Sofosbuvir and daclatasvir combination therapy in hemodialysis patient with liver transplantation].
Topics: Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Hepatitis C; Humans; Imidazoles; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sofosbuvir; Treatment Outcome; Valine | 2016 |